Gerwin Huls

4.1k citations

59 papers · 2.8k indexed · 1 hit paper · h-index 19

Impact in

Oncology top 5%
- Cancer Cells and Metastasis
Hematology top 5%
- Acute Myeloid Leukemia Research

Papers in

Hematology 24
- Acute Myeloid Leukemia Research 19
Immunology 18
- Immune Cell Function and Interaction 9
- Phagocytosis and Immune Regulation 5
- Immunotherapy and Immune Responses 4

Co-authors: Hans Clevers Petra Moerer Nick Barker Vladimír Kořínek Elly van Donselaar Roel Goldschmeding Moniek van Beest Ton Logtenberg
Journals: Blood (9 papers)HemaSphere (5 papers)Haematologica (4 papers)Blood Advances (3 papers)Leukemia (2 papers)
Partner nations: Netherlands United States Belgium

In The Last Decade

Gerwin Huls

55 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4 1998 · 1.3k citations

Peers

Countries citing papers authored by Gerwin Huls

Since Specialization

Citations

This map shows the geographic impact of Gerwin Huls's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerwin Huls with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerwin Huls more than expected).

Fields of papers citing papers by Gerwin Huls

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerwin Huls. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerwin Huls. The network helps show where Gerwin Huls may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerwin Huls, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerwin Huls Line = papers co-authored together Gerwin Huls links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Acute promyelocytic leukaemia in low-income and middle-income countries: a Brazilian experience The Lancet Haematology ·Diego A. Pereira‐Martins, Isabel Weinhäuser, Juan Luiz Coelho‐Silva, Emanuele Ammatuna, Gerwin Huls, Jan Jacob Schuringa, Eduardo Magalhães Rego, Antonio R. Lucena‐Araujo	2024	1
2	DGAT1 Inhibition Enhances Metformin-Induced Ferroptosis in AML By Targeting Lipid Metabolism Blood ·Peng Yeong Pin, Diego A. Pereira‐Martins, Kosato Kinoshita, Samuel Perry Johnston, Ming Yang, Yoke Chen Poon, Mario Weder, Merilee Ford, Sow Mariama Oury, Jennifer Barger, Emanuele Ammatuna, Gerwin Huls, Christian Frezza, Lynn Quek, Jan Jacob Schuringa	2024	2
3	Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemia Haematologica ·Jennifer Barger, 伊佐夫池谷, Rae-Anna Hedlin, Min Chul Kwon, Albertus T.J. Wierenga, Fiona A.J. van den Heuvel, Vincent van den Boom, Anna Kuchnio, Ulrike Philippar, Gerwin Huls, Jan Jacob Schuringa	2024	2
4	Improved Outcome of Allogeneic Transplantation in Older Patients Treated for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Reduced Duration of Immune Suppression Transplantation and Cellular Therapy ·Linde M. Morsink, Maximiano Pastrana Santos, Goda Choi, Marco R. de Groot, 饶益刚, Mar Bellido, 啓正立原, Laura Bungener, Kees Meijer, André B. Mulder, Gerwin Huls	2024	4
5	Hypothyroidism, comorbidity and health-related quality of life: a population-based study Endocrine Connections ·Hanneke J. C. M. Wouters, Bruce H. R. Wolffenbuttel, Anneke C. Muller Kobold, Thera P. Links, Gerwin Huls, Melanie M. van der Klauw	2023	4
6	R‐miniCHOP versus R‐CHOP in elderly patients with diffuse large B‐cell lymphoma: A propensity matched population‐based study American Journal of Hematology ·Stephanie Lanzarone, Mirian Brink, Martine E.D. Chamuleau, Rolf E. Brouwer, José Luis Mego Meléndez, Djamila E. Issa, Wendy Deenik, Gerwin Huls, Rogier Mous, Joost S.P. Vermaat, Arjan Diepstra, Josée M. Zijlstra, Tom van Meerten, Marcel Nijland	2023	11
7	Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance Cell Death Discovery ·Ghizlane Choukrani, Nienke Visser, Astrid Kaempfe, Morten Oxenboell, Rebecca D Onie, Emanuele Ammatuna, 崔珣, Toshiro Niki, Gerwin Huls, Edwin Bremer, Valerie R. Wiersma	2023	6
8	Radiotherapy Is an Excellent Bridging Strategy in Large B-Cell Lymphoma Patients Selected for CAR T-Cell Therapy Blood ·Pablo Fernando De Jesús Pérez, Jaap A. van Doesum, Max Beijert, Marcel Nijland, Johannes A. Langendijk, Dianne M. Busz, T. Tsige-Tamirat, Gerwin Huls, Tom van Meerten	2021	3
9	Galectin-9 Triggers Neutrophil-Mediated Anticancer Immunity Biomedicines ·Astrid Kaempfe, Ghizlane Choukrani, Emanuele Ammatuna, Toshiro Niki, Ewa Cendrowicz, 崔珣, Gerwin Huls, Valerie R. Wiersma, Edwin Bremer	2021	14
10	CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clones Blood Advances ·Ivan P. Pistelli, Prajna Harish, Kees Meijer, Linde M. Morsink, Jennifer Barger, Carolien M. Woolthuis, Emanuele Ammatuna, J. S. Webster, Bauke de Boer, Gerwin Huls, André B. Mulder, Jan Jacob Schuringa	2021	7
11	The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia iScience ·Antonietta Della Ragione, 一也忠岡, Jennifer Barger, Aida Rodríguez López, Jennifer Jaques, Morten Oxenboell, Marcel P. de Vries, 熊谷重城, Annet Z. Brouwers-Vos, Electra Nenedaki, Tang Kai-li, reza sohrabi kabi, Gerwin Huls, Nakamura Kaori, Joost H.A. Martens, Vincent van den Boom, Jan Jacob Schuringa	2021	27
12	CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL Cancer Immunology Research ·哲男宮沢, Yuan He, 우용제, 啓正立原, Ewa Cendrowicz, Rudolf S.N. Fehrmann, Emanuele Ammatuna, Christine zu Eulenburg, Marcel Nijland, Gerwin Huls, Edwin Bremer, Tom van Meerten	2019	28
13	Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study PLoS Medicine ·Michele F. Eisenga, Maarten A. de Jong, Peter van der Meer, David E. Leaf, Gerwin Huls, Ilja M. Nolte, Sandrine Gaillard, Stephan J. L. Bakker, Martin H. de Borst	2019	21
14	Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach PLoS ONE ·悟坂本, Lydia Visser, Gerwin Huls, Arjan Diepstra, Marcel A.T.M. van Vugt, Emanuele Ammatuna, Rozemarijn S. van Rijn, Edo Vellenga, Anke van den Berg, Rudolf S.N. Fehrmann, Roberto Menichelli	2018	18
15	ANALYSIS OF NEW GFI1B VARIANTS IN PATIENTS WITH INHERITED BLEEDING AND PLATELET DISORDERS Haematologica ·Anna E. Marneth, Ruud van Oorschot, Saskia M. Bergevoet, Michael Chaumun, Ernest Turro, Imagine Study, Waander L. van Heerde, Gerwin Huls, Cătălin Tilișcan, Willem H. Ouwehand, Kate Downes, Kathleen Freson, Bert A. van der Reijden	2015	2
16	Loss of quiescence and impaired function of CD34+/CD38low cells one year following autologous stem cell transplantation Haematologica ·Carolien M. Woolthuis, Annet Z. Brouwers-Vos, Gerwin Huls, J. Th. M. de Wolf, Jan Jacob Schuringa, Edo Vellenga	2013	12
17	MLL–AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny Leukemia ·Sarah J. Horton, Katarina Juričević, Carolien M. Woolthuis, Johannes van Dijk, Maria Mesuraca, Gerwin Huls, Giovanni Morrone, Edo Vellenga, Jan Jacob Schuringa	2012	65
18	Auto-SCT induces a phenotypic shift from CMP to GMP progenitors, reduces clonogenic potential and enhances in vitro and in vivo cycling activity defined by 18F-FLT PET scanning Bone Marrow Transplantation ·Carolien M. Woolthuis, Sirad Mohamoud, Sandra Olthof, Riemer H. J. A. Slart, Gerwin Huls, W. M. Smid, Jan Jacob Schuringa, Edo Vellenga	2010	8
19	Resistant Microascus cirrosus pneumonia can be treated with a combination of surgery, multiple anti-fungal agents and a growth factor Mycopathologia ·Celalettin Üstün, Gerwin Huls, Kiri Louise Hagerman, Kieren A. Marr	2006	18
20	Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4 Nature Genetics ·Vladimír Kořínek, Nick Barker, Petra Moerer, Elly van Donselaar, Gerwin Huls, Ruhani Baweja, Hans Clevers Hit paper breakdown →	1998	1259

About Gerwin Huls

Gerwin Huls is a scholar working on Hematology, Immunology, Oncology, Genetics and Pathology and Forensic Medicine, having authored 59 papers that have together received 2.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (19 papers), CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Phagocytosis and Immune Regulation (5 papers), Viral-associated cancers and disorders (4 papers), Immunotherapy and Immune Responses (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Oncology (844 citations), Hematology (312 citations), Molecular Biology (1.8k citations), Genetics (202 citations) and Immunology (377 citations). Gerwin Huls has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Hans Clevers, Petra Moerer, Nick Barker, Vladimír Kořínek, Elly van Donselaar, Roel Goldschmeding, Moniek van Beest, Ton Logtenberg, Jeroen P. Roose and JH Kleibeuker. Their work appears in journals such as Blood, HemaSphere, Haematologica, Blood Advances and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact